QA: 2Seventy bio Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001860782_2024_2Seventy_bio_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 0.9176458670988655, 'aggregate_val': 37862000, 'exp_sum': 19744000, 'exp_to_value': {'remainder_Revenues': 19744000}}

Graph

Absolute values for 0001860782, 2Seventy bio Inc

  xvar xval
0 AssetsCurrent 237,765,000
1 IntangibleAssetsNetIncludingGoodwill 6,594,000
2 PropertyPlantAndEquipmentNet 58,150,000
3 remainder_Assets 262,917,000
4 LiabilitiesCurrent 59,779,000
5 LiabilitiesNoncurrent 250,347,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 2,099,000
8 SellingGeneralAndAdministrativeExpense 69,414,000
9 ResearchAndDevelopmentExpense 230,758,000
10 remainder_Expenses 35,724,000
11 remainder_Revenues 100,387,000
12 remainder_NetIncome 20,038,000
13 remainder_ComprehensiveNetIncome 2,673,000
  yvar yval
0 Assets 565,426,000
1 Liabilities 310,126,000
2 Expenses 337,995,000
3 Revenues 100,387,000
4 StockholdersEquity 255,300,000
5 NetIncome -217,570,000
6 ComprehensiveNetIncome -216,233,500
7 BaseVar 668,322,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.777
9 EconomicCapitalRatio 2.12

Edgar->Model Mapping

Feature Distribution

Change over Time